Preclinical Testing of eSVS Mesh*

The eSVS Mesh has been studied in a variety of preclinical models to confirm that the device performs as expected. These animal trials showed a statistically significant inhibition of the formation of intimal hyperplasia when the eSVS Mesh was used with an SVG in CABG procedures.** Preclinical trials of the eSVS Mesh technology have been presented in peer-reviewed journals including The Journal of Thoracic and Cardiovascular Surgery in February 2008 and the Journal of Vascular Surgery in June 2009.



Untreated SVG
Mid-grafts cross-sections and histological staining showing intimal proliferation and thrombus formation with luminal reduction. 
SVG with the eSVS Mesh 

Mid-graft sections and histological stain showing normal intimal and fully functioning endothelial layer with no luminal loss.


Caution: Investigational Device Limited by Federal (or United States) law to investigational use
This device is commercially available for use in select international markets


** Human clinical studies may not be consistent with animal trial results.